These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 463245)

  • 1. [The chronic, recurrent, cervical and lumbar vertebrae syndromes. Effect of vincamine depot in patients with chronic, recurrent, cervical and lumbar vertebrae syndromes].
    Kühle A
    ZFA (Stuttgart); 1979 Jun; 55(17):1043-6. PubMed ID: 463245
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic, recurrent, cervical-spine syndrome. Therapeutic observations with vincamin-depot].
    Kühle A
    ZFA (Stuttgart); 1979 Jan; 55(3):188-91. PubMed ID: 419815
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy of chronic cerebrovascular arteriosclerotic insufficiency in a geriatric patient].
    Cucinotta D; Palummeri E; Carapezzi C; Cocchi C
    G Clin Med; 1979 Mar; 60(3):225-33. PubMed ID: 520728
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evaluation of the anti-platelet aggregation action of oxovinca in the diffuse vascular deterioration syndrome].
    Jubert Gruart J; Canals R; Balaguer M
    Med Clin (Barc); 1983 Jan; 80(1):10-2. PubMed ID: 6834913
    [No Abstract]   [Full Text] [Related]  

  • 5. [Controlled clinical study on the activity of vincamine-teprosylate in the so-called aging brain syndrome].
    Passeri M; Cucinotta D; Mancini M; Bia A; Palummeri E
    G Clin Med; 1982; 63(11-12):874-87. PubMed ID: 7182206
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vincamine in cerebrovascular insufficiency. Occupational medicine approaches in cerebral diseases].
    Steinhäuser B
    Fortschr Med; 1986 Jan; 104(1-2):23-6. PubMed ID: 3949275
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the vincamine-papaverine association iii. clinical use in cardiac patients.
    Pirani R; Cattani L; Tomasi AM; Masoni A
    Agressologie; 1978; 19(3):221-5. PubMed ID: 736222
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vincamine in the therapy of cerebral vascular diseases in the aged].
    De Candia O; Bartolucci E; Mancinella A; Baghiris D
    Clin Ter; 1979 May; 89(4):373-80. PubMed ID: 535317
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects induced by vincamine teprosilate on chronic cerebrovascular disease: preliminary results.
    Lanfranchi M; Magnani G; Sinforiani E; Casali R
    Int J Clin Pharmacol Res; 1984; 4(4):307-12. PubMed ID: 6389380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral antioedematous effect of Teproside and of some vincamine derivatives.
    Borzeix MG; Cahn J
    Int J Clin Pharmacol Res; 1984; 4(4):259-61. PubMed ID: 6500773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug therapy in cerebral disorders. A double-blind study with Cetal retard in aged subjects].
    Schenker H
    Med Klin; 1979 Oct; Suppl():48-50. PubMed ID: 542168
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of vincamine on experimental cerebral infarction in Mongolian gerbils: a pilot study.
    Ritschel WA; Mandybur TI; Grummich KW; Means ED
    Methods Find Exp Clin Pharmacol; 1984 Mar; 6(3):131-4. PubMed ID: 6748817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of the clinical effects of vincamine + glycerol versus glycerol + placebo in the acute phase of stroke.
    Dekoninck WJ; Jocquet P; Jacquy J; Henriet M
    Arzneimittelforschung; 1978; 28(9):1654-7. PubMed ID: 383107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Controlled testing of vincamine with special reference to the flow properties of blood].
    Klein M; Szobor A; Bräuer H
    Med Klin; 1979 Oct; Suppl():29-36. PubMed ID: 542163
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic influence of vincamine on impairment of cerebral performance in elderly patients. Results of a double-blind study (author's transl)].
    Schenker H
    Schweiz Rundsch Med Prax; 1979 Jul; 68(31):1005-11. PubMed ID: 379854
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the effect of vincamine teprosilate on behavioural performances of patients affected with chronic cerebrovascular disease.
    Casale R; Giorgi I; Guarnaschelli C
    Int J Clin Pharmacol Res; 1984; 4(4):313-9. PubMed ID: 6500778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Double-blind controlled study of the effects of vincamine hydrochloride on some parameters of cardiovascular function in aged bronchopneumopathic patients].
    Mazzola C; Della Torre F; Izzo M; Colombo Pirola L
    Clin Ter; 1979 Dec; 91(5):485-503. PubMed ID: 397034
    [No Abstract]   [Full Text] [Related]  

  • 18. [Double-blind study of the therapeutic activity of cerebroxine in the treatment of chronic cerebral circulatory insufficiency].
    Holemans P
    Brux Med; 1979 May; 59(5):279-85. PubMed ID: 380784
    [No Abstract]   [Full Text] [Related]  

  • 19. [Psychoactive effect of vincamine in a group of subjects affected by recurrent depressive syndrome. Preliminary note].
    Crispi G; Di Lorenzo RS; Gentile A; Florino A; Pannone B; Sciorio G
    Minerva Med; 1975 Oct; 66(70):3683-5. PubMed ID: 1103012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical, psychological and neurophysiological results of double-blind study on vincamine-cromesilate in patients with cerebro-vascular insufficiency (author's transl)].
    Mikus P
    Arzneimittelforschung; 1978; 28(11):2165-8. PubMed ID: 582924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.